Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-28 18:20:33 - browse：5722

Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT — Jonathan Wosen for STAT

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Printout prescription drug information shouldn’t go digital

entertainment

WSS

Inaction leaves children at risk from dangerous chemotherapy drug

To bolster infectious disease surveillance, genomics powerhouses team up

CVS is on a mission to consolidate health care. Will it work?

Disappointing trial forces Pfizer to pivot on obesity medicine plans

The inclusion problem at the heart of rehabilitation research

High breast density mammograms need follow

explore

Wikipedia

hotspot

Alkermes shareholders re

Fetal surgery at risk from Dobbs and new abortion restrictions

Bright Health sells Medicare Advantage business to Molina

Prior authorization reform is both possible and imperative

Trump demands the U.S. pay no more for drugs than other countries … again

Mass General, Mayo Clinic look to monetize custom

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Mayo Clinic plans $5B tech

What does generative AI mean for health care? We asked experts

TikTok, Instagram influencers need more rules for drug ads

entertainment

The EPA's new lead rule: How one expert crunched the numbers

HPV vaccine, cervical cancer study delivers historic results

UnitedHealth’s Optum accused of antitrust violations in California

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Will the market for weight loss drugs really reach $100 billion?

Mass General, Mayo Clinic look to monetize custom

focus

hotspot

entertainment

knowledge